Granulomatous lymphocytic interstitial lung disease as a complication of common variable immunodeficiency
https://doi.org/10.18093/0869-0189-2021-31-6-816-821
Abstract
Common variable immunodeficiency (CVID) is a rare immunodeficiency, the classic manifestation being recurrent infections. Other lesions are often found in CVID patients, such as malignant neoplasms, autoimmune conditions caused by abnormal cellular immunity, in addition to infectious complications. Usually, the pathological process involves the lungs. This article presents a clinical case of a patient with CVID complicated by granulomatous lymphocytic interstitial lung disease.
About the Authors
Alexandr V. Averyanov
Federal Pulmonology Research Institute, Federal Medical and Biological Agency of Russia
Russian Federation
Competing Interests:
Russian Federation
Doctor of Medicine, chief researcher, Federal Pulmonology Research Institute.
Orekhovyy bul’var 28, Moscow, 115682; tel.: (495) 395-05-11
Competing Interests:
no
Anastasia S. Perkina
Federal Pulmonology Research Institute, Federal Medical and Biological Agency of Russia; Federal Scientific and Clinical Center for Specialized Types of Medical Care and Medical Technologies, Federal Medical and Biological Agency of Russia
Russian Federation
Competing Interests:
Russian Federation
Researcher, Laboratory of Personified Medicine, Federal Pulmonology Research Institute, Federal Mand BAR, Pulmonologist, Federal Scientific and Clinical Center for Specialized Types of Medical Care and Medical Technologies, FMBAR.
Orekhovyy bul’var 28, Moscow, 115682; Orekhovyy bul’var 28, Moscow, 115682; tel.: (963) 721-00-98
Competing Interests:
no
References
1. Cunningham-Rundles C., Bodian C. Common variable immunodeficiency: clinical and immunological features of 248 patients. Clin. Immunol. 1999; 92 (1): 34-48. DOI: 10.1006/clim.1999.4725.
2. Odnoletkova I., Kindle G., Quinti I. et al. The burden of common variable immunodeficiency disorders: a retrospective analysis of the European Society for Immunodeficiency (ESID) registry data. Or-phanet J. Rare Dis. 2018; 13 (1): 201. DOI: 10.1186/s13023-018-0941-0.
3. Baloh C., Reddy A., Henson M. et al. 30-year review of pediatric-and adult-onset CVID: clinical correlates and prognostic indicators. J. Clin. Immunol. 2019; 39 (7): 678-687. DOI: 10.1007/s10875-019-00674-9.
4. Amika A.K., Funkhouser W., Handly B. et al. Granulomatous-lymphocytic interstitial lung disease in 22q11.2 deletion syndrome: a case report and literature review. Curr. Allergy Asthma Rep. 2018; 18 (3): 14. DOI:10.1007/s11882-018-0769-7.
5. Gupta S., Pattanaik D., Krishnaswamy G. Common variable immune deficiency and associated complications. Chest. 2019; 156 (3): 579-593. DOI: 10.1016/j.chest.2019.05.009.
6. Yazdani R., Abolhassani H., Asgardoon M.H. et al. Infectious and noninfectious pulmonary complications in patients with primary immunodeficiency disorders. J. Investig. Allergol. Clin. Immunol. 2017; 27 (4): 213-224. DOI: 10.18176/jiaci.0166.
7. Bates C.A., Ellison M.C., Lynch D.A. et al. Granulomatous-lymphocytic lung disease shortens survival in common variable immunodeficiency. J. Allergy Clin. Immunol. 2004; 114 (2): 415-421. DOI: 10.1016/j.jaci.2004.05.057.
8. Hurst J.R., Verma N., Lowe D. et al. British lung foundation/United Kingdom primary immunodeficiency network consensus statement on the definition, diagnosis, and management of granulomatous-lymphocytic interstitial lung disease in common variable immunodeficiency disorders. J. Allergy Clin. Immunol. Pract. 2017; 5 (4): 938-945. DOI: 10.1016/j.jaip.2017.01.021.
9. Xiao X., Miao Q., Chang C. et al. Common variable immunodeficiency and autoimmunity - an inconvenient truth. Autoimmun. Rev. 2014; 13 (8): 858-864. DOI: 10.1016/j.autrev.2014.04.006.
10. Mannina A., Chung J.H., Swigris J.J. et al. Clinical predictors of a diagnosis of common variable immunodeficiency-related granulomatous-lymphocytic interstitial lung disease. Ann. Am. Thorac. Soc. 2016; 13 (7): 1042-1049. DOI: 10.1513/annalsats.201511-728oc.
11. Hartono S., Motosue M.S., Khan S. et al. Predictors of granulomatous lymphocytic interstitial lung disease in common variable immunodeficiency. Ann. Allergy Asthma Immunol. 2017. 118 (5): 614-620. DOI: 10.1016/j.anai.2017.01.004.
12. Cinetto F., Scarpa R., Pulvirenti F. et al. Appropriate lung management in patients with primary antibody deficiencies. Expert Rev. Respir. Med. 2019; 13 (9): 823-838. DOI: 10.1080/17476348.2019.1641085.
13. Torigian D., LaRosa D., Levinson A. et al. Granulomatous-lymphocytic interstitial lung disease associated with common variable immunodeficiency: CT finding. J. Thorac. Imaging. 2008; 23 (3):162—169. DOI: 10.1097/rti.0b013e318166d32f.
14. Cereser L., Giromettib R., d’Angelo P. et al. Humoral primary immunodeficiency diseases: clinical overview and chest high-resolution computed tomography (HRCT) features in the adult population. Clin. Radiol. 2017; 72 (7): 534-542. DOI: 10.1016/j.crad.2017.03.018.
15. Jolles S., Carne E., Brouns M. et al. FDG PET-CT imaging of therapeutic response in granulomatous lymphocytic interstitial lung disease (GLILD) in common variable immunodeficiency (CVID). Clin. Exp. Immunol. 2017; 187 (1): 138-145. DOI: 10.1111/cei.12856.
16. Rao N., Mackinnon A.C., Routes J.M. et al. Granulomatous and lymphocytic interstitial lung disease (GLILD): a spectrum of pulmonary histopathological lesions in common variable immunodeficiency (CVID) - histological and immunohistochemical analysis of 16 cases. Hum. Pathol. 2015; 46 (9): 1306-1314. DOI: 10.1016/j.humpath.2015.05.011.
17. Tashtoush B., Memarpour R., Ramirez J. et al. Granulomatous-lymphocytic interstitial lung disease as the first manifestation of common variable immunodeficiency. Clin. Respir. J. 2018; 12 (1): 337-343. DOI: 10.1111/crj.12511.
18. Chase N.M., Verbsky J.W., Hintermeyer M.K. et al. Use of combination chemotherapy for treatment of granulomatous and lymphocytic interstitial lung disease (GLILD) in patients with common variable immunodeficiency (CVID). J. Clin. Immunol. 2013; 33 (1): 30-39. DOI: 10.1007/s10875-012-9755-3.
19. DeyiUMarfinez A., Esteve-Sol6 A., V6lez-Tirado N. et al. Sirolimus as an alternative treatment in patients with granulomatous-lymphocytic lung disease and humoral immunodeficiency with impaired regulatory T-cells. Pediatr. Allergy Immunol. 2018; 29 (4): 425-432. DOI: 10.1111/pai.12890.
Review
For citations:
Averyanov A.V., Perkina A.S. Granulomatous lymphocytic interstitial lung disease as a complication of common variable immunodeficiency. PULMONOLOGIYA. 2021;31(6):816-821. (In Russ.) https://doi.org/10.18093/0869-0189-2021-31-6-816-821
Views:
865
Email this article 